Literature DB >> 31572905

Systematic literature review investigating whether methotrexate causes chronic pulmonary fibrosis.

Ed Quah1, Constanta Amoasii1, Tareg Mudawi1, Julie Dawson1.   

Abstract

Entities:  

Year:  2019        PMID： 31572905      PMCID： PMC6752445          DOI： 10.7861/futurehosp.6-2s-s4

Source DB:  PubMed          Journal:  Future Healthc J        ISSN： 2514-6645


× No keyword cloud information.
  6 in total

1.  Chronic pulmonary toxicity of methotrexate and rheumatoid arthritis.

Authors:  G Provenzano
Journal:  Rheumatology (Oxford)       Date:  2003-06       Impact factor: 7.580

2.  Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis.

Authors:  Jorge Rojas-Serrano; Denisse Herrera-Bringas; Diana I Pérez-Román; Renzo Pérez-Dorame; Heidegger Mateos-Toledo; Mayra Mejía
Journal:  Clin Rheumatol       Date:  2017-06-06       Impact factor: 2.980

3.  Investigation of the chronic pulmonary effects of low-dose oral methotrexate in patients with rheumatoid arthritis: a prospective study incorporating HRCT scanning and pulmonary function tests.

Authors:  J K Dawson; D R Graham; J Desmond; H E Fewins; M P Lynch
Journal:  Rheumatology (Oxford)       Date:  2002-03       Impact factor: 7.580

4.  Progressive interstitial lung disease from prolonged methotrexate therapy.

Authors:  R L Kaplan; D H Waite
Journal:  Arch Dermatol       Date:  1978-12

5.  Pulmonary complications following methotrexate therapy.

Authors:  T J Phillips; D H Jones; H Baker
Journal:  J Am Acad Dermatol       Date:  1987-02       Impact factor: 11.527

6.  Methotrexate-induced diffuse interstitial pulmonary fibrosis.

Authors:  C W Bedrossian; W C Miller; M A Luna
Journal:  South Med J       Date:  1979-03       Impact factor: 0.954
  6 in total
  2 in total

Review 1.  Immunotargets and Therapy for Prurigo Nodularis.

Authors:  Angelina Labib; Teresa Ju; Ashley Vander Does; Gil Yosipovitch
Journal:  Immunotargets Ther       Date:  2022-04-26

2.  Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome Manifesting as Lymphocytic Interstitial Pneumonia and Treatment-Resistant Bullous Pemphigoid.

Authors:  Stine Maria Andersen; Simon Fage; Sune Leisgaard Rubak; Mette Holm; Jens Magnus Bernth Jensen; Trine Mogensen; Mette Deleuran
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2021-06       Impact factor: 0.885
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.